327
Views
1
CrossRef citations to date
0
Altmetric
Review

Effect of Tuberculosis (TB) and Diabetes mellitus (DM) integrated healthcare on bidirectional screening and treatment outcomes among TB patients and people living with DM in developing countries: a systematic review

ORCID Icon, , &

References

  • WHO. Noncommunicable diseases: progress monitor 2020 [Internet]. Geneva PP - Geneva: World Health Organization; 2020. Accessed 19 October 2021. Available from: https://apps.who.int/iris/handle/10665/330805
  • Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2· 3 million patients with tuberculosis. Lancet Glob Heal. 2019;7(4):e448–60.
  • Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2019;157:107843.
  • WHO. Global report on diabetes [Internet]. 978, 2020. Accessed 03 May 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
  • McMurry HS, Mendenhall E, Rajendrakumar A, et al. Coprevalence of type 2 diabetes mellitus and tuberculosis in low-income and middle-income countries: a systematic review. Diabetes Metab Res Rev. 2019 Jan;35(1):e3066.
  • Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract [Internet]. 2018;138:271–281. Available from http://www.sciencedirect.com/science/article/pii/S0168822718302031
  • Harries AD, Satyanarayana S, Kumar AM, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action. 2013 Nov;3(Suppl 1):S3–9.
  • Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(1):81.
  • Ruslami R, Aarnoutse RE, Alisjahbana B, et al. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Heal. 2010;15(11):1289–1299.
  • Harries A, Lin Y, Kumar AMV, et al. What can national TB control programmes in low- and middle-income countries do to end tuberculosis by 2030? F1000Research [Internet]. 2018 Jul 5;7:F1000 Faculty Rev-1011. Accessed 20 May 2019. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30026917
  • Lönnroth K, Roglic G, Harries AD. Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol. 2014;2(9):730–739.
  • Harries AD, Kumar AM, Satyanarayana V, et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis [Internet]. 2015 Aug [cited 2017 Feb 7];19(8):879–886. Available from. http://www.ncbi.nlm.nih.gov/pubmed/26162352
  • Harries A, Am V K, Satyanarayana S, et al. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop Med Hyg. 2016;110(3):173.
  • Alebel A, Wondemagegn AT, Tesema C, et al. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis [Internet]. 2019;19(1):254.
  • Jeon CY, Harries AD, Baker MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Heal [Internet]. 2010 Nov 1;15(11):1300–1314.
  • Wagnew F, Eshetie S, Alebel A, et al., Meta-analysis of the prevalence of tuberculosis in diabetic patients and its association with cigarette smoking in African and Asian countries. BMC Res Notes [Internet]. 2018 May 15;11(1):298. Available from
  • Kumar A, Gupta D. Screening of patients with diabetes mellitus for tuberculosis in India. Trop Med Int Heal [Internet]. 2013 May cited 2017 Jun 22;18(5):646–654. Available from h tt p://d oi.wi ley.c om/10.1 111/tmi.1 2084
  • Nsonga J, Dongo JP, Mugabe F, et al. Screening tuberculosis patients for diabetes mellitus in a routine program setting in Kampala, Uganda: a cross-sectional study. F1000Res. 2019 Jun 17;8:872. [Internet]. Accessed 21 March 2020. https://pubmed.ncbi.nlm.nih.gov/31681473
  • Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Heal. 2012;17(10):1294–1301.
  • Jali M-V, Mahishale V-K, Hiremathi M-B. Bidirectional screening of tuberculosis patients for diabetes mellitus and diabetes patients for tuberculosis. Diabetes Metab J [Internet]. 2013;37(4):291–295.
  • Liu H, Muhunthan J, Hayek A, et al. Examining the use of process evaluations of randomised controlled trials of complex interventions addressing chronic disease in primary health care—a systematic review protocol. Syst Rev [Internet]. 2016 Dec 15 [cited 2017 Feb 9];5(1):138. Available from http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0314-5
  • Tegegne BS, Mengesha MM, Teferra AA, et al. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev. 2018;7(1):1–13.
  • Worswick J, Wayne SC, Bennett R, et al. Improving quality of care for persons with diabetes: an overview of systematic reviews-what does the evidence tell us? Syst Rev. 2013;2(1):26.
  • Watkins DA, Tulloch NL, Anderson ME, et al. Delivery of health care for cardiovascular and metabolic diseases among people living with HIV/AIDS in African countries: a systematic review protocol. Syst Rev. [Internet]. 2016 Dec 16 cited 2017 Feb 9;5(1):63. Available from http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0241-5
  • Graham-Rowe E, Lorencatto F, Lawrenson JG, et al. Barriers and enablers to diabetic retinopathy screening attendance: protocol for a systematic review. Syst Rev. 2016;5(1):134. 2016.
  • Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med [Internet]. 2011 Dec 1 cited 2017 Feb 9;9(1):81. Available from http://www.ncbi.nlm.nih.gov/pubmed/21722362
  • Deng C, Wang X, Liao Y. Current recommendations on managing tuberculosis patients with diabetes & its epidemiology. Microb Pathog. [Internet]. 2016 Mar cited 2017 Feb 9;92:43–45. Available from http://linkinghub.elsevier.com/retrieve/pii/S0882401015301911
  • Damery S, Flanagan S, Combes G. The effectiveness of interventions to achieve co-ordinated multidisciplinary care and reduce hospital use for people with chronic diseases: study protocol for a systematic review of reviews. Syst Rev. 2015;4(1):64.
  • Marais BJ, Lönnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis [Internet]. 2013 May cited 2017 Jun 23;13(5):436–448. Available from http://linkinghub.elsevier.com/retrieve/pii/S147330991370015X
  • van Crevel R, van de Vijver S, Moore DAJ. The global diabetes epidemic: what does it mean for infectious diseases in tropical countries? Lancet Diabetes Endocrinol. 2017 Mar;5(6):457–468.
  • Jeon CY, Harries AD, Baker MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Heal [Internet]. 2010 Nov cited 2017 Feb 9;15(11):1300–1314. Available from h tt p://d oi.wi ley.c om/1 0.1 11 1/j.13 65-3156.2010.026 32.x
  • Mills A. Health care systems in low- and middle-income countries. N Engl J Med. 2014;370(6):552–557.
  • Oelke ND, Suter E, da Silva Lima MAD, et al. Indicators and measurement tools for health system integration: a knowledge synthesis protocol. Syst Rev. 2015;4(1):99.
  • Campbell JR, Sasitharan T, Marra F. A systematic review of studies evaluating the cost utility of screening high-risk populations for latent tuberculosis infection. Appl Health Econ Health Policy. 2015;13(4):325–340.
  • Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10(1):28–55.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. [Internet]. 2009;62(10):e1–34. Available from http://www.sciencedirect.com/science/article/pii/S0895435609001802
  • Briggs CJ, Garner P. Strategies for integrating primary health services in middle‐ and low‐income countries at the point of delivery. Cochrane Database Syst Rev [Internet]. 2006 2; Available from h ttp s://d oi.org//1 0.1002/14 651858.CD00331 8.pub 2
  • Lou LM, Kennedy CE, Bain‐Brickley D, et al. Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev. 2012;9:1–54.
  • World Bank. Countries and economies [Internet]. The world bank group. 2021. Accessed 06 September 2021. Available from: https://data.worldbank.org/country
  • Tegegne BS, Habtewold TD, Mengesha MM, et al. Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev. 2017 Jan;6(1):6.
  • Stovold E, Beecher D, Foxlee R, et al. Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram. Syst Rev. 2014;3(1):1–5.
  • Cochrane Airways. Data collection form– rCTs and NRS [Internet]. 2021. Accessed 04 September 2021. https://airways.cochrane.org/data-collection
  • Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions. UK: John Wiley & Sons; 2019.
  • Castellanos-Joya M, Delgado-Sánchez G, Ferreyra-Reyes L, et al. Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS One. 2014 Sep;9(9):e106961.
  • Zhang X-L, S-g L, H-t L, et al. Integrating tuberculosis screening into annual health examinations for the rural elderly improves case detection. Int J Tuberc Lung Dis. 2015;19(7):787–791.
  • Ncube RT, Dube SA, Machekera SM, et al. Feasibility and yield of screening for diabetes mellitus among tuberculosis patients in Harare, Zimbabwe. Public Health Action. [Internet]. 2019 Jun 21;9(2):72–77. Available from.https://pubmed.ncbi.nlm.nih.gov/31417857
  • Kumar A, Gupta D. Screening of patients with tuberculosis for diabetes mellitus in India. Trop Med Int Health. 2013 May;18(5):636–645.
  • Segafredo G, Kapur A, Robbiati C, et al. Integrating TB and non-communicable diseases services: pilot experience of screening for diabetes and hypertension in patients with Tuberculosis in Luanda, Angola. PLoS One. [Internet]. 2019 Jul 5;14(7):e0218052–e0218052. Available from https://pubmed.ncbi.nlm.nih.gov/31276500
  • Ma Y, Pang Y, Shu W, et al. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up. Eur J Clin Microbiol Infect Dis. 2018;37(7):1259–1263.
  • Ruslami R, Koesoemadinata RC, Soetedjo NNM, et al. The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: a randomized trial. Diabetes Res Clin Pract. 2021;173:108701.
  • Robertson D, Williams GH. Clinical and translational science: principles of human research. London (UK): Academic Press; 2009.
  • Jali MV, Mahishale VK HM. Bidirectional screening of tuberculosis patients for diabetes mellitus and diabetes patients for tuberculosis. Chest. 2013;144(4):1–2.
  • Kumar A, Gupta D, Nagaraja SB, et al. Screening of patients with diabetes mellitus for tuberculosis in India. Trop Med Int Heal. 2013;18(5):646–654.
  • Sterne JAC, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. [Internet]. 2016 Oct 12;355:i4919. Available from http://www.bmj.com/content/355/bmj.i4919.abstract
  • on behalf of the development group for ACROBAT-NRSI, Sterne JAC, Higgins JPT, Reeves BC. A cochrane risk of bias assessment tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI). Version. 2014;1
  • Basir MS, Habib SS, Zaidi SMA, et al. Operationalization of bi-directional screening for tuberculosis and diabetes in private sector healthcare clinics in Karachi, Pakistan. BMC Health Serv Res [Internet]. 2019;19(1):147.
  • Majumdar A, Wilkinson E, Rinu PK, et al. Tuberculosis-diabetes screening: how well are we doing? A mixed-methods study from North India. Public Health Action. 2019;9(1):3–10.
  • Jerene D, Hiruy N, Jemal I, et al. The yield and feasibility of integrated screening for TB, diabetes and HIV in four public hospitals in Ethiopia. Int Health. 2017;9(2):100–104.
  • Skordis-Worrall J, Round J, Arnold M, et al. Addressing the double-burden of diabetes and tuberculosis: lessons from Kyrgyzstan. Global Health. 2017;13(1):16.
  • Munseri PJ, Kimambo H, Pallangyo K. Diabetes mellitus among patients attending TB clinics in Dar Es Salaam: a descriptive cross-sectional study. BMC Infect Dis [Internet]. 2019 Oct 29;19(1):915.
  • Tenaye L, Mengiste B, Baraki N, et al. Diabetes mellitus among adult tuberculosis patients attending tuberculosis clinics in Eastern Ethiopia. Babu S, editor. Biomed Res Int [Internet]. 2019; 2019:7640836.
  • Ekeke N, Aniwada E, Chukwu J, et al. Screening diabetes mellitus patients for tuberculosis in Southern Nigeria: a pilot study. Adv Respir Med. 2020;88(1):6–12.
  • Riza AL, Pearson F, Ugarte-Gil C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol [Internet]. 2014 Sep cited 2017 Jun 5;2(9):740–753. Available from http://linkinghub.elsevier.com/retrieve/pii/S221385871470110X
  • Marupuru S, Senapati P, Pathadka S, et al. Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility. Brazilian J Infect Dis. 2017;21(3):312–316.
  • Jorgensen ME, Faurholt-Jepsen D. Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review. Curr Diab Rep. 2014;14(7). DOI:10.1007/s11892-014-0505-1
  • Adopted by the 18th WMA general assembly Helsinki Finland. WMA declaration of Helsinki -ethical principles for medical research involving human subjects. WMA Gen Assem. 2013.18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.